Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with

Bone Marrow Hematopoietic Stem Cell Transplantation Humans Leukemia, Myeloid, Acute / genetics Remission Induction fms-Like Tyrosine Kinase 3 / genetics

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
06 2020
Historique:
received: 19 11 2019
accepted: 19 03 2020
pubmed: 4 4 2020
medline: 28 4 2021
entrez: 4 4 2020
Statut: ppublish

Résumé

The

Identifiants

DOI: 10.3324/haematol.2019.243410 PMID: 32241850 PMC: PMC7271578
pubmed: 32241850
pii: haematol.2019.243410
doi: 10.3324/haematol.2019.243410
pmc: PMC7271578
doi:

Substances chimiques

FLT3 protein, human EC 2.7.10.1
fms-Like Tyrosine Kinase 3 EC 2.7.10.1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1507-1516

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

J Clin Oncol. 2019 Jul 1;37(19):1604-1607
pubmed: 31034300
Blood Cancer J. 2016 Jul 29;6(7):e449
pubmed: 27471865
Leukemia. 2013 Feb;27(2):260-8
pubmed: 22797419
Cancer. 2020 Mar 1;126(5):1004-1015
pubmed: 31774557
Biol Blood Marrow Transplant. 2016 Jul;22(7):1218-1226
pubmed: 27058617
Clin Hematol Int. 2019 Mar 18;1(1):10-18
pubmed: 34595406
Ann Hematol. 2018 Jun;97(6):967-975
pubmed: 29423758
Blood. 2015 Oct 22;126(17):2062-9
pubmed: 26351297
Am J Hematol. 2019 Sep;94(9):984-991
pubmed: 31237017
Blood Adv. 2018 Oct 23;2(20):2744-2754
pubmed: 30341082
Blood. 2013 Jun 6;121(23):4655-62
pubmed: 23613521
Clin Hematol Int. 2020 Mar;2(1):27-31
pubmed: 32190831
JAMA Oncol. 2018 Sep 1;4(9):1245-1253
pubmed: 30003233
Bone Marrow Transplant. 2019 Sep;54(9):1462-1470
pubmed: 30710101
Blood. 2020 Jan 30;135(5):371-380
pubmed: 31826241
Ann Hematol. 2017 Dec;96(12):1993-2003
pubmed: 29090343
Biol Blood Marrow Transplant. 2013 Dec;19(12):1713-8
pubmed: 24076323
Haematologica. 2017 Feb;102(2):391-400
pubmed: 27846611
Ther Adv Hematol. 2019 Nov 01;10:2040620719882666
pubmed: 31700594
Lancet Oncol. 2015 Dec;16(16):1691-9
pubmed: 26549589
Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e545-e550
pubmed: 30082225
Blood. 2000 Dec 1;96(12):3907-14
pubmed: 11090077
Leuk Lymphoma. 2013 Apr;54(4):760-6
pubmed: 23061485
Cancer. 2018 May 1;124(9):1954-1963
pubmed: 29509276
J Clin Oncol. 2013 Sep 1;31(25):3110-8
pubmed: 23897964
N Engl J Med. 2016 Feb 4;374(5):422-33
pubmed: 26789727
Blood. 1999 May 1;93(9):3074-80
pubmed: 10216104
Haematologica. 2011 Jan;96(1):62-8
pubmed: 20952518
Blood. 2001 Sep 15;98(6):1752-9
pubmed: 11535508
J Natl Compr Canc Netw. 2019 Jun 1;17(6):721-749
pubmed: 31200351
Blood. 2008 Feb 1;111(3):1552-9
pubmed: 17940205
Leukemia. 2017 Jan;31(1):26-33
pubmed: 27416910
N Engl J Med. 2019 Oct 31;381(18):1728-1740
pubmed: 31665578
Blood. 2001 Apr 15;97(8):2434-9
pubmed: 11290608
Clin Lymphoma Myeloma Leuk. 2017 Apr;17(4):241-242
pubmed: 28196687
Genes Cancer. 2010 Oct;1(10):1021-32
pubmed: 21779428
Biol Blood Marrow Transplant. 2016 Jun;22(6):982-990
pubmed: 26785334
Biol Blood Marrow Transplant. 2011 Dec;17(12):1874-7
pubmed: 21767516
N Engl J Med. 2012 Mar 22;366(12):1079-89
pubmed: 22417203
Blood. 2013 Apr 4;121(14):2734-8
pubmed: 23377436
Blood. 2007 Mar 1;109(5):2264-5; author reply 2265
pubmed: 17312001
Blood. 2010 Oct 14;116(15):2858-9
pubmed: 20947691
Leukemia. 1996 Dec;10(12):1911-8
pubmed: 8946930
Biol Blood Marrow Transplant. 2016 Mar;22(3):462-9
pubmed: 26551637
Haematologica. 2019 Sep;104(9):e398-e401
pubmed: 30792203
Blood. 2014 Nov 27;124(23):3441-9
pubmed: 25270908
Clin Hematol Int. 2019 May 10;1(2):94-100
pubmed: 34595416
Blood. 2015 Jul 16;126(3):319-27
pubmed: 25852056
Oncogene. 2000 Feb 3;19(5):624-31
pubmed: 10698507
Clin Lymphoma Myeloma Leuk. 2015 May;15(5):298-302
pubmed: 25550214
Mol Cell. 2004 Jan 30;13(2):169-78
pubmed: 14759363
Blood Adv. 2017 Feb 28;1(7):477-485
pubmed: 29296964
J Clin Oncol. 2013 Oct 10;31(29):3681-7
pubmed: 24002496
J Clin Oncol. 2013 Nov 1;31(31):3889-97
pubmed: 24062400
Clin Hematol Int. 2019 Mar 18;1(1):58-74
pubmed: 34595412
Am J Hematol. 2018 Jun;93(6):736-744
pubmed: 29498106
Semin Hematol. 2016 Apr;53(2):82-9
pubmed: 27000731
Haematologica. 2013 Apr;98(4):518-25
pubmed: 22983588
Leukemia. 2000 Apr;14(4):675-83
pubmed: 10764154
N Engl J Med. 2013 May 30;368(22):2059-74
pubmed: 23634996
Blood. 2019 Feb 21;133(8):840-851
pubmed: 30563875
Blood Adv. 2017 Aug 17;1(19):1546-1550
pubmed: 29296796
Leuk Res. 2013 Mar;37(3):287-92
pubmed: 23276395
J Clin Oncol. 2012 Mar 1;30(7):735-41
pubmed: 22291086
Ann Hematol. 2015 Nov;94(11):1899-905
pubmed: 26233683
Leukemia. 2012 Nov;26(11):2353-9
pubmed: 22504140
Blood. 2008 Mar 1;111(5):2527-37
pubmed: 17965322
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Bone Marrow Transplant. 2017 Mar;52(3):344-351
pubmed: 27775694
Lancet Haematol. 2019 Nov;6(11):e573-e584
pubmed: 31477550
Eur J Haematol. 2017 Apr;98(4):348-354
pubmed: 27893163
Blood. 2015 Nov 26;126(22):2491-501
pubmed: 26438511
Eur J Cancer. 2017 Nov;86:233-239
pubmed: 29055209
Blood. 2002 Dec 15;100(13):4372-80
pubmed: 12393388
Cancer Res. 2001 Oct 1;61(19):7233-9
pubmed: 11585760
Blood. 2007 Aug 15;110(4):1262-70
pubmed: 17456725
N Engl J Med. 2008 May 1;358(18):1909-18
pubmed: 18450602
Clin Lymphoma Myeloma Leuk. 2019 Aug;19(8):506-508
pubmed: 31122828
Blood. 2008 Mar 1;111(5):2776-84
pubmed: 17957027
Cancer. 2017 Aug 1;123(15):2867-2874
pubmed: 28387928
J Adv Nurs. 1994 Jan;19(1):180-6
pubmed: 8138622
Haematologica. 2014 Nov;99(11):e222-4
pubmed: 25015937
J Hematol Oncol. 2017 Jan 18;10(1):20
pubmed: 28100265
Blood. 2002 Sep 1;100(5):1532-42
pubmed: 12176867
Leuk Res. 2010 Oct;34(10):e270-2
pubmed: 20627386
Blood. 2006 May 15;107(10):4011-20
pubmed: 16455956
Biol Blood Marrow Transplant. 2014 Dec;20(12):2042-8
pubmed: 25239228
Leukemia. 2005 Aug;19(8):1345-9
pubmed: 15959528
Cell. 2007 Jun 29;129(7):1261-74
pubmed: 17604717
Lancet Oncol. 2019 Jul;20(7):984-997
pubmed: 31175001
Blood. 2017 Jan 26;129(4):424-447
pubmed: 27895058
Blood. 2009 Sep 17;114(12):2386-92
pubmed: 19602710
Br J Haematol. 2016 Nov;175(3):496-504
pubmed: 27434660
Biol Blood Marrow Transplant. 2012 Dec;18(12):1845-50
pubmed: 22766221
Best Pract Res Clin Haematol. 2008 Jun;21(2):291-307
pubmed: 18503994
Blood. 2005 Nov 15;106(10):3658-65
pubmed: 16076872
Nat Med. 2018 Mar;24(3):282-291
pubmed: 29431743
Neoplasma. 2007;54(1):89-94
pubmed: 17233551
Haematologica. 2003 Jan;88(1):19-24
pubmed: 12551822
Microbiol Mol Biol Rev. 2004 Jun;68(2):320-44
pubmed: 15187187
Bone Marrow Transplant. 2012 Dec;47(12):1535-7
pubmed: 22659680
Ther Adv Hematol. 2019 Feb 15;10:2040620719827310
pubmed: 30800259
Cancer. 2019 Nov 1;125(21):3755-3766
pubmed: 31310323
Biol Blood Marrow Transplant. 2011 Sep;17(9):1404-9
pubmed: 21324374
Clin Transplant. 2015 Feb;29(2):149-60
pubmed: 25430616
Blood. 2002 Jun 15;99(12):4326-35
pubmed: 12036858
N Engl J Med. 2017 Aug 3;377(5):454-464
pubmed: 28644114
Cancer. 2016 Oct;122(19):3005-3014
pubmed: 27315441
Am J Hematol. 2017 Apr;92(4):331-337
pubmed: 28052408
Blood. 2006 Jul 1;108(1):400; author reply 400-1
pubmed: 16790584
Blood. 2018 Mar 22;131(12):1275-1291
pubmed: 29330221

Auteurs

Ali Bazarbachi (A)

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon bazarbac@aub.edu.lb.
Department of Anatomy, Cell Biology, and Physiological Sciences, American University of Beirut, Beirut, Lebanon.

Gesine Bug (G)

Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.

Frederic Baron (F)

GIGA-I3, University and CHU of Liège, Liège, Belgium.

Eolia Brissot (E)

Sorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.

Fabio Ciceri (F)

Vita-Salute San Raffaele University of Milan, Milan, ItalyHematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Iman Abou Dalle (IA)

Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

Hartmut Döhner (H)

Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.

Jordi Esteve (J)

Hematology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcellona, Spain.

Yngvar Floisand (Y)

Department of Hematology, Oslo University Hospital - Rikshospitalet, Oslo, Norway.
Center for Cancer Cell Reprogramming, Institute for Cancer Research, Oslo University Hospital, Montebello, Oslo, Norway.

Sebastian Giebel (S)

Department of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.

Maria Gilleece (M)

Department of Haematology, Leeds Teaching Hospitals Trust, Leeds, UK.

Norbert-Claude Gorin (NC)

Department of Hematology and Cell Therapy, European Society for Blood and Marrow Transplantation, Paris Office, Hopital Saint-Antoine, Paris, France.

Elias Jabbour (E)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mahmoud Aljurf (M)

Department of Hematology King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.

Hagop Kantarjian (H)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Mohamed Kharfan-Dabaja (M)

Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, FL, USA.

Myriam Labopin (M)

Acute Leukemia Working Party, Paris Study Office, European Society for Blood and Marrow Transplantation, Paris, France.
Sorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.

Francesco Lanza (F)

Romagna Transplant Network, Ravenna, Italy.

Florent Malard (F)

Sorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.

Zinaida Peric (Z)

University Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.

Thomas Prebet (T)

Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Farhad Ravandi (F)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Annalisa Ruggeri (A)

Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Roma, ItalyEurocord, Hôpital Saint Louis, Paris, France.

Jaime Sanz (J)

Hematology Department, Hospital Universitari i Politecnic La Fe. Instituto de Investigación Sanitaria La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, Spain.

Christoph Schmid (C)

Department of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany.

Roni Shouval (R)

Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Alexandros Spyridonidis (A)

BMT Unit, University of Patras, Patras, Greece.

Jurjen Versluis (J)

Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.

Norbert Vey (N)

Department of Hematology, Institut Paoli-Calmettes, Marseille, France.

Bipin N Savani (BN)

Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

Arnon Nagler (A)

Hematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Israel.

Mohamad Mohty (M)

Sorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Moelle osseuse › Clinical practice recommendation on...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Clinical practice recommendation on...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Clinical practice recommendation on...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Leucémies › Leucémie myéloïde › Leucémie aigüe myéloïde › Clinical practice recommendation on...
questionsmedicales.fr › Thérapeutique › Induction de rémission › Clinical practice recommendation on...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines oncogènes › Protéines proto-oncogènes › Tyrosine kinase-3 de type fms › Clinical practice recommendation on...